Literature DB >> 27025239

Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.

Michael T Massengill1, Hassan M Ashraf1, Rajib R Chowdhury1, Stephen M Chrzanowski1, Jeena Kar1, Sonisha A Warren1, Glenn A Walter1, Huadong Zeng2, Byung-Ho Kang3, Robert H Anderson4, Richard L Moss5, Hideko Kasahara6.   

Abstract

AIMS: Under pressure overload, initial adaptive hypertrophy of the heart is followed by cardiomyocyte elongation, reduced contractile force, and failure. The mechanisms governing the transition to failure are not fully understood. Pressure overload reduced cardiac myosin light chain kinase (cMLCK) by ∼80% within 1 week and persists. Knockdown of cMLCK in cardiomyocytes resulted in reduced cardiac contractility and sarcomere disorganization. Thus, we hypothesized that acute reduction of cMLCK may be causative for reduced contractility and cardiomyocyte remodelling during the transition from compensated to decompensated cardiac hypertrophy. METHODS AND
RESULTS: To mimic acute cMLCK reduction in adult hearts, the floxed-Mylk3 gene that encodes cMLCK was inducibly ablated in Mylk3(flox/flox)/merCremer mice (Mylk3-KO), and compared with two control mice (Mylk3(flox/flox) and Mylk3(+/+)/merCremer) following tamoxifen injection (50 mg/kg/day, 2 consecutive days). In Mylk3-KO mice, reduction of cMLCK protein was evident by 4 days, with a decline to below the level of detection by 6 days. By 7 days, these mice exhibited heart failure, with reduction of fractional shortening compared with those in two control groups (19.8 vs. 28.0% and 27.7%). Severely convoluted cardiomyocytes with sarcomeric disorganization, wavy fibres, and cell death were demonstrated in Mylk3-KO mice. The cardiomyocytes were also unable to thicken adaptively to pressure overload.
CONCLUSION: Our results, using a new mouse model mimicking an acute reduction of cMLCK, suggest that cMLCK plays a pivotal role in the transition from compensated to decompensated hypertrophy via sarcomeric disorganization. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Heart failure; Inducible knockout; Kinase

Mesh:

Substances:

Year:  2016        PMID: 27025239      PMCID: PMC4909160          DOI: 10.1093/cvr/cvw069

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  47 in total

Review 1.  Structure and regulation of calcium/calmodulin-dependent protein kinases.

Authors:  T R Soderling; J T Stull
Journal:  Chem Rev       Date:  2001-08       Impact factor: 60.622

2.  Phospholamban pentamers attenuate PKA-dependent phosphorylation of monomers.

Authors:  Tanja Wittmann; Martin J Lohse; Joachim P Schmitt
Journal:  J Mol Cell Cardiol       Date:  2015-01-03       Impact factor: 5.000

3.  Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.

Authors:  Farah Sheikh; Kunfu Ouyang; Stuart G Campbell; Robert C Lyon; Joyce Chuang; Dan Fitzsimons; Jared Tangney; Carlos G Hidalgo; Charles S Chung; Hongqiang Cheng; Nancy D Dalton; Yusu Gu; Hideko Kasahara; Majid Ghassemian; Jeffrey H Omens; Kirk L Peterson; Henk L Granzier; Richard L Moss; Andrew D McCulloch; Ju Chen
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

4.  Myosin light chain kinase (MLCK) regulates cell migration in a myosin regulatory light chain phosphorylation-independent mechanism.

Authors:  Chen Chen; Tao Tao; Cheng Wen; Wei-Qi He; Yan-Ning Qiao; Yun-Qian Gao; Xin Chen; Pei Wang; Cai-Ping Chen; Wei Zhao; Hua-Qun Chen; An-Pei Ye; Ya-Jing Peng; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

Review 5.  Chasing cardiac physiology and pathology down the CaMKII cascade.

Authors:  Alicia Mattiazzi; Rosana A Bassani; Ariel L Escobar; Julieta Palomeque; Carlos A Valverde; Martín Vila Petroff; Donald M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

Review 6.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

7.  Myosin light chain phosphorylation is critical for adaptation to cardiac stress.

Authors:  Sonisha A Warren; Laura E Briggs; Huadong Zeng; Joyce Chuang; Eileen I Chang; Ryota Terada; Moyi Li; Maurice S Swanson; Stewart H Lecker; Monte S Willis; Francis G Spinale; Julie Maupin-Furlowe; Julie R McMullen; Richard L Moss; Hideko Kasahara
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

Review 8.  Alterations in ryanodine receptors and related proteins in heart failure.

Authors:  Sameer Ather; Jonathan L Respress; Na Li; Xander H T Wehrens
Journal:  Biochim Biophys Acta       Date:  2013-06-14

9.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

10.  Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Authors:  Norimichi Koitabashi; Djahida Bedja; Ari L Zaiman; Yigal M Pinto; Manling Zhang; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

View more
  17 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Myosin light chain phosphorylation, novel targets to repair a broken heart?

Authors:  Danuta Szczesna-Cordary; Pieter P de Tombe
Journal:  Cardiovasc Res       Date:  2016-05-17       Impact factor: 10.787

Review 3.  Role of myosin light chain phosphatase in cardiac physiology and pathophysiology.

Authors:  Audrey N Chang; Kristine E Kamm; James T Stull
Journal:  J Mol Cell Cardiol       Date:  2016-10-11       Impact factor: 5.000

Review 4.  Transmural gradients of myocardial structure and mechanics: Implications for fiber stress and strain in pressure overload.

Authors:  Eric D Carruth; Andrew D McCulloch; Jeffrey H Omens
Journal:  Prog Biophys Mol Biol       Date:  2016-11-11       Impact factor: 3.667

Review 5.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

6.  Heart Failure Induced by Perinatal Ablation of Cardiac Myosin Light Chain Kinase.

Authors:  Yasmin F K Islam; Ryan Joseph; Rajib R Chowdhury; Robert H Anderson; Hideko Kasahara
Journal:  Front Physiol       Date:  2016-10-26       Impact factor: 4.566

Review 7.  miR-133: A Suppressor of Cardiac Remodeling?

Authors:  Ning Li; Heng Zhou; Qizhu Tang
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

8.  Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1.

Authors:  Rong Zhang; Yi Xu; Huifang Niu; Ting Tao; Tao Ban; Linyao Zheng; Jing Ai
Journal:  J Cell Mol Med       Date:  2018-08-17       Impact factor: 5.310

9.  Pressure Overload-induced Cardiac Hypertrophy Varies According to Different Ligation Needle Sizes and Body Weights in Mice.

Authors:  Zhen Jia; Zhijun Chen; Hongfei Xu; Malik Akuffu Armah; Peng Teng; Weidong Li; Dongdong Jian; Liang Ma; Yiming Ni
Journal:  Arq Bras Cardiol       Date:  2018-06       Impact factor: 2.000

10.  Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.

Authors:  Matthias Heinig; Michiel E Adriaens; Sebastian Schafer; Hanneke W M van Deutekom; Elisabeth M Lodder; James S Ware; Valentin Schneider; Leanne E Felkin; Esther E Creemers; Benjamin Meder; Hugo A Katus; Frank Rühle; Monika Stoll; François Cambien; Eric Villard; Philippe Charron; Andras Varro; Nanette H Bishopric; Alfred L George; Cristobal Dos Remedios; Aida Moreno-Moral; Francesco Pesce; Anja Bauerfeind; Franz Rüschendorf; Carola Rintisch; Enrico Petretto; Paul J Barton; Stuart A Cook; Yigal M Pinto; Connie R Bezzina; Norbert Hubner
Journal:  Genome Biol       Date:  2017-09-14       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.